We are live on ! Find out more
CBST

CUBIST PHARMACEUTICALS INC
CBST

Delisted

CBST was delisted on the 21st of January, 2015.

Back to rankings

254 hedge funds and large institutions have $5.31B invested in CUBIST PHARMACEUTICALS INC in 2014 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 105 increasing their positions, 91 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

15% more repeat investments, than reductions

Existing positions increased: 105 | Existing positions reduced: 91

3% less capital invested

Capital invested by funds: $5.5B → $5.31B (-$188M)

6% less funds holding

Funds holding: 270 → 254 (-16)

18% less call options, than puts

Call options by funds: $35.7M | Put options by funds: $43.4M

25% less funds holding in top 10

Funds holding in top 10: 8 → 6 (-2)

34% less first-time investments, than exits

New positions opened: 25 | Existing positions closed: 38

Holders
254
Holders Change
-16
Holders Change %
-5.93%
% of All Funds
7.37%
Holding in Top 10
6
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-25%
% of All Funds
0.17%
New
25
Increased
105
Reduced
91
Closed
38
Calls
$35.7M
Puts
$43.4M
Net Calls
-$7.72M
Net Calls Change
+$422M

Top Buyers

Rank Fund Capital Flow
1
PC
PointState Capital
New York
+$61.1M
2
PI
Putnam Investments
Massachusetts
+$60.3M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$49.6M
4
Bank of New York Mellon
Bank of New York Mellon
New York
+$40.1M
5
PAI
Palo Alto Investors
California
+$20.8M

Top Sellers

Rank Fund Capital Flow
1
O
OppenheimerFunds
New York
-$39.6M
2
Deutsche Bank
Deutsche Bank
Germany
-$37.2M
3
Norges Bank
Norges Bank
Norway
-$27.8M
4
RIM
RS Investment Management
California
-$27.3M
5
First Trust Advisors
First Trust Advisors
Illinois
-$23.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
MLICM
101
Metropolitan Life Insurance Company (MetLife)
New York
$4.42M +$48.6K +740 +1%
CC
102
Coastland Capital
California
$4.24M +$3.26M +49,700 +350%
Comerica Bank
103
Comerica Bank
Texas
$4.17M +$48.7K +742 +1%
Nordea Investment Management
104
Nordea Investment Management
Sweden
$3.86M +$52.5K +800 +1%
AC
105
Apex Capital
California
$3.78M +$3.74M +57,000 New
State of Wisconsin Investment Board
106
State of Wisconsin Investment Board
Wisconsin
$3.67M +$24.3K +370 +0.7%
PA
107
Profund Advisors
Maryland
$3.66M +$113K +1,727 +3%
N
108
Nuveen
North Carolina
$3.66M +$416K +6,340 +13%
Jacobs Levy Equity Management
109
Jacobs Levy Equity Management
New Jersey
$3.59M +$2.11M +32,069 +146%
GH
110
GAM Holding
Switzerland
$3.58M +$460K +7,000 +15%
PAMU
111
Pictet Asset Management (UK)
United Kingdom
$3.51M -$2.01M -30,600 -37%
MCM
112
Mazama Capital Management
Oregon
$3.47M -$1.83M -27,859 -35%
ACM
113
Advent Capital Management
New York
$3.44M -$120K -1,827 -3%
CWM
114
CIBC World Markets
New York
$3.33M +$307K +4,667 +10%
Capstone Investment Advisors
115
Capstone Investment Advisors
New York
$3.29M -$644K -9,800 -16%
TA
116
Teachers Advisors
New York
$3.26M -$86.1K -1,311 -3%
SIA
117
Sit Investment Associates
Minnesota
$3.13M -$1.31M -20,000 -30%
ASRS
118
Arizona State Retirement System
Arizona
$3.12M -$118K -1,800 -4%
RSCM
119
Rock Springs Capital Management
Maryland
$3.08M +$493K +7,500 +19%
BFM
120
Boston Financial Management
Massachusetts
$3.06M +$40K +609 +1%
IAM
121
Impax Asset Management
New Hampshire
$3.03M -$276K -4,203 -8%
WMSA
122
Weiss Multi-Strategy Advisers
New York
$2.98M +$266K +4,050 +10%
DekaBank Deutsche Girozentrale
123
DekaBank Deutsche Girozentrale
Germany
$2.94M +$75.5K +1,150 +3%
RFC
124
Russell Frank Company
Washington
$2.83M +$484K +7,366 +21%
WA
125
Whitebox Advisors
Minnesota
$2.82M – – –
3 4
5
6 7

CBST Hedge Fund Activity: Q3 2014 in Review

254 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in CUBIST PHARMACEUTICALS INC (CBST) for Q3 2014, worth a combined $5.31B — down 3.4% from $5.5B a quarter earlier.

Sellers outnumbered buyers: 38 funds closed out of CBST and 25 opened new positions — a net loss of 13 holders — while 91 trimmed existing stakes and 105 added.

The largest buyer was PointState Capital, adding an estimated $61.1M. The largest seller was OppenheimerFunds, exiting entirely with an estimated $39.6M sold.

  • 254 institutional investors held CUBIST PHARMACEUTICALS INC (CBST) as of Q3 2014, down from 270 in Q2 2014.
  • Funds reported $5.31B of CUBIST PHARMACEUTICALS INC stock for Q3 2014, down 3.4% quarter-over-quarter.
  • 25 funds opened new CUBIST PHARMACEUTICALS INC positions in Q3 2014 and 38 closed out, a net change of -13 holders.
  • The largest CUBIST PHARMACEUTICALS INC buyer in Q3 2014 was PointState Capital, an estimated $61.1M added.
  • The largest CUBIST PHARMACEUTICALS INC seller in Q3 2014 was OppenheimerFunds, an estimated $39.6M sold.

Based on aggregated 13F filings for Q3 2014.